Senseonics Holdings Inc (SENS)
0.3227
+0.01
(+1.70%)
USD |
NYAM |
Nov 21, 16:00
0.322
0.00 (0.00%)
Pre-Market: 08:16
Senseonics Holdings Enterprise Value: 170.58M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 170.58M |
| November 20, 2024 | 167.38M |
| November 19, 2024 | 167.62M |
| November 18, 2024 | 158.38M |
| November 15, 2024 | 147.12M |
| November 14, 2024 | 147.41M |
| November 13, 2024 | 156.66M |
| November 12, 2024 | 166.02M |
| November 11, 2024 | 171.00M |
| November 08, 2024 | 162.17M |
| November 07, 2024 | 188.36M |
| November 06, 2024 | 176.57M |
| November 05, 2024 | 177.40M |
| November 04, 2024 | 179.12M |
| November 01, 2024 | 180.66M |
| October 31, 2024 | 179.39M |
| October 30, 2024 | 181.70M |
| October 29, 2024 | 186.01M |
| October 28, 2024 | 183.23M |
| October 25, 2024 | 163.76M |
| October 24, 2024 | 169.43M |
| October 23, 2024 | 166.32M |
| October 22, 2024 | 177.40M |
| October 21, 2024 | 170.47M |
| October 18, 2024 | 174.95M |
| Date | Value |
|---|---|
| October 17, 2024 | 170.31M |
| October 16, 2024 | 173.14M |
| October 15, 2024 | 171.40M |
| October 14, 2024 | 176.85M |
| October 11, 2024 | 172.49M |
| October 10, 2024 | 159.34M |
| October 09, 2024 | 164.36M |
| October 08, 2024 | 162.40M |
| October 07, 2024 | 165.83M |
| October 04, 2024 | 166.49M |
| October 03, 2024 | 161.03M |
| October 02, 2024 | 162.29M |
| October 01, 2024 | 163.27M |
| September 30, 2024 | 170.14M |
| September 27, 2024 | 155.29M |
| September 26, 2024 | 153.74M |
| September 25, 2024 | 161.02M |
| September 24, 2024 | 153.53M |
| September 23, 2024 | 154.54M |
| September 20, 2024 | 161.08M |
| September 19, 2024 | 165.04M |
| September 18, 2024 | 187.86M |
| September 17, 2024 | 201.41M |
| September 16, 2024 | 179.55M |
| September 13, 2024 | 186.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
120.82M
Minimum
Oct 28 2020
2.004B
Maximum
Feb 16 2021
499.28M
Average
269.42M
Median
Jun 20 2023
Enterprise Value Benchmarks
| Abbott Laboratories | 210.81B |
| DexCom Inc | 29.03B |
| Baxter International Inc | 28.43B |
| Boston Scientific Corp | 143.48B |
| Perspective Therapeutics Inc | -63.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.98M |
| Revenue (Quarterly) | 4.263M |
| Total Expenses (Quarterly) | 27.11M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | -95.03% |
| Profit Margin (Quarterly) | -562.4% |
| Earnings Yield | -40.29% |
| Normalized Earnings Yield | -40.36 |